Mairbek Taisumov has accepted a six-month suspension from the United States Anti-Doping Agency, the organization announced Thursday.
Per a release, Taisumov tested positive for a pair of stanozolol metabolites, 3′-hydroxystanozolol-O-glucuronide and 16β-hydroxystanozolol-O-glucuronide. The metabolites were discovered in an in-competition sample collected on Sept. 15, 2018 at UFC Moscow, where Taisumov defeated Desmond Green by unanimous decision. There is no mention of whether the result of that bout will be overturned as that ruling will be determined by the UFC.
Stanozolol is prohibited year-round under USADA policy. Taisumov’s suspension is retroactive to Oct.